Research

At monthly faculty meetings, basic and clinical immunologists discuss ongoing research in their labs in order to foster translation of immunological principles into clinical immunotherapy trials. Immunologists in other departments are part of our vibrant immunology community and contribute expertise in many important areas of immunology and immunotherapy:

• Gordon Freeman, PhD: PD-1 and PD-L1 pathway in cancer
• F. Stephen Hodi, Jr., MD: clinical trials of novel immunotherapy agents
• David Reardon, MD: immunotherapy of CNS tumors
• Jerome Ritz, MD: adoptive cellular therapies
• Margaret A. Shipp, MD: B cell lymphomas
• Catherine J. Wu, MD: personalized cancer vaccines